Analyses of cell signals provide insight into the origin of severe inflammatory symptoms that appear in various types of blood cancer and point to possible therapeutic approaches: In around one-fourth of patients suffering from juvenile myelomonocytic leukemia (JMML), there is evidence of mutations in the so-called KRAS gene in the leukemia cells. Patients affected by JMML carrying these mutations suffer particularly often from signs of inflammation, such as fever, weight loss, and an abnormal enlargement of the spleen.
It was previously unknown how the sometimes severe inflammatory symptoms are connected with the cancer. A team of researchers has now demonstrated that the cancer-causing mutation in the KRAS gene is also the cause of the inflammation. The improved understanding of the symptoms will enable doctors to develop new drugs for blocking the progression of leukemia in the body.
The KRAS gene regulates the production of the K-Ras protein, which gives the cells instructions to grow or to divide. The protein ensures that cells only multiply if new cells are needed in the body. If K-Ras is excessively active in some cells due to a mutation in the genetic material, these cells divide unchecked - and cancer develops.
The team have now discovered that K-Ras also plays an important role in the immune response: Via the NLRP3 protein complex - also known as the NLRP3 inflammasome - it leads to the release of two inflammation-promoting messenger substances, interleukin-1β and interleukin-18, which the researchers succeeded in detecting in cells from blood samples of leukemia patients. When the researchers inhibited the formation of the messenger substances with drugs, this treatment not only relieved the inflammatory symptoms but also slowed down tumor growth.
"This is a promising result that is also consistent with other studies demonstrating that cancer-causing mutations influence the production of interleukin messengers," explains the author. The results of the study show that the signaling pathways whose disruption leads to cancer are also directly related to the signaling processes of the immune response.
http://www.pr.uni-freiburg.de/pm-en/press-releases-2020/cancer-mutation-in-dual-role
https://www.nature.com/articles/s41467-020-15497-1
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Foncogenic-krasg12d&filter=22
KRAS mutation also causes inflammation in cancer patients
- 2,086 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Harmful protein waste in the muscle from a genetic disorder
Read more
Natural selection opposes sexual selection
Read more
Largescale brain epigenetics study discovers 84 new genes linked to…
Read more
Rescuing the synapse at nerve-muscle junction with antibody therapy
Read more
Controlling neuronal hyperactivity in Bourneville's tuberous sclero…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar